ESMO members: ELCC presentations, webcasts and abstracts from previous days are published!
Haven't had much time lately? Here's what you may have missed in the last few weeks.
Sign-up to receive the OncologyPRO alert
every 2 weeks.
Find all the latest ESMO Guidelines
, new Pan Asian Guidelines
and
discover the ESMO Guidelines Slide Sets
!
For full access to all OncologyPRO content: daily medwireNews, ESMO books, slides and webcasts... and much more.
Become an ESMO member today!
17 Apr 2019
Analysis of clinical trial data suggests that older individuals with non-small-cell lung cancer derive a survival benefit from immunotherapy, whereas...
16 Apr 2019
Adjuvant tamoxifen given at a daily dose of 5 mg for 3 years could be an option for individuals with resected breast intraepithelial neoplasia
15 Apr 2019
Maintenance nivolumab given alone or alongside ipilimumab has failed to improve the overall survival of patients with extensive-stage SCLC that has...
12 Apr 2019
Pembrolizumab has achieved a response in PD-L1-positive cervical cancer patients with disease that has progressed on or during chemotherapy
11 Apr 2019
The creation of clinicogenomic database could help support research into non-small-cell lung cancer
Reporting from AACR 2019 in Atlanta, M. Garassino comments on two studies about the immunotherapy outcomes in NSCLC patients presenting with brain or liver metastasis, and the use of Tumour Mutational Burden as a biomarker in metastatic NSCLC patients.
10-13 Apr 2019, Geneva, Switzerland
24-28 Mar 2019, Berlin, Germany
22-24 Mar 2019, Sao Paulo, Brazil
14-16 Mar 2019, Barcelona, Spain
06-08 Mar 2019, Manchester, United Kingdom
25-27 Feb 2019, Paris, France
22-22 Feb 2019, Valencia, Spain
15-17 Feb 2019, Cape Town, South Africa
01-02 Feb 2019, Lugano, Switzerland
13-16 Dec 2018, Geneva, Switzerland
02-03 Dec 2018, Milan, Italy
26-27 Nov 2018, Singapore
26-27 Nov 2018, Singapore
23-25 Nov 2018, Singapore, Singapore
23-24 Nov 2018, Zurich, Switzerland
